Expression of and cytokine activation by Escherichia coli curli fibers in human sepsis

Journal of Infectious Diseases

Volumn 181, Issue 2, 2000, Pages 602-612

  Bian, Zhao ^a   Brauner, Annelie ^b   Li, Yinghua ^b   Normark, Staffan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ESCHERICHIA COLI; FEMALE; HUMAN; MACROPHAGE ACTIVATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BACTEREMIA; BACTERIAL PROTEINS; CONGO RED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; FIBRONECTINS; HUMANS; IMMUNOBLOTTING; MACROPHAGE ACTIVATION; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 0034006823     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315233     Document Type: Article

References (50)

1. Bone RC. The sepsis syndrome: definition and general approach to management. Clin Chest Med 1996; 17:175-81.
2. de Boer JP, Creasey AA, Chang A, et al. Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern. Infect Immun 1993; 61:4293-301.
3. DeLa Cadena RA, Suffredini AF, Page FD, et al. Activation of the kallikreinkinin system after endotoxin administration to normal human volunteers. Blood 1993; 81:3313-7.
4. Pixley RA, De La Cadena R, Page JD, et al. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia: in vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J Clin Invest 1993; 91:61-8.
5. Dinarello CA. Cytokines as mediators in the pathogenesis of septic shock. Curr Top Microbiol Immunol 1996; 216:133-65.
6. Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Annu Rev Med 1987; 38:417-32.
7. Ziegler EJ, Fisher CJ Jr, Sprung CL, et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human mono-clonal antibody against endotoxin: a randomized, double-blind, placebo-controlled trial. N Engl J Med 1991; 324:429-36.
8. Greenman RL, Schein RM, Martin MA, et al. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 1991; 266:1097-102.
9. Barriere S, Guglielmo BJ. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. Clin Pharm 1992; 11:223-35.
10. Olsen A, Jonsson A, Normark S. Fibronectin binding mediated by a novel class of surface organelles on Escherichia coli. Nature 1989; 338:652-5.
11. Collinson SK, Emödy L, Muller KH, Trust TJ, Kay WW. Purification and characterization of thin, aggregative fimbriae from Salmonella enteritidis. J Bacteriol 1991; 173:4773-81.
12. Olsen A, Arnqvist A, Hammar M, Sukupolvi S, Normark S. The RpoS sigma factor relieves H-NS-mediated transcriptional repression of csgA, the subunit gene of fibronectin-binding curli in Escherichia coli. Mol Microbiol 1993; 7:523-36.
13. Hammar M, Arnqvist A, Bian Z, Olsen A, Normark S. Expression of 2 csg operons is required for production of fibronectin and congo red-binding curli polymers in Escherichia coli K-12. Mol Microbiol 1995; 18:661-70.
14. Hammar M, Bian Z, Normark S. Nucleator-dependent intercellular assembly of adhesive curli organelles in Escherichia coli. Proc Natl Acad Sci U S A 1996; 93:6562-6.
15. Bian Z, Normark S. Nucleator function of CsgB for the assembly of adhesive surface organelles in Escherichia coli. EMBO J 1997; 16:5827-36.
16. Sjöbring U, Pohl G, Olsen A. Plasminogen, absorbed by Escherichia coli expressing curli or by Salmonella enteritidis expressing thin aggregative fimbriae, can be activated by simultaneously captured tissue-type plasminogen activator (t-PA). Mol Microbiol 1994; 14:443-52.
17. Ben Nasr A, Olsen A, Sjöbring U, Mulleresterl W, Björck L. Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli. Mol Microbiol 1996; 20:927-35.
18. Olsen A, Wick MJ, Morgelin M, Bjorck L. Curli, fibrous surface proteins of Escherichia coli, interact with major histocompatibility complex class I molecules. Infect Immun 1998; 66:944-9.
19. Herwald H, Morgelin M, Olsen A, et al. Activation of the contact-phase system on bacterial surfaces: a clue to serious complications in infectious diseases. Nat Med 1998; 4:298-302.
20. Casadaban MJ. Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu. J Mol Biol 1976; 104:541-55.
21. Evans DG, Evans DJ Jr, Tjoa W. Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect Immun 1977; 18:330-7.
22. Römling U, Sierralta WD, Eriksson K, Normark S. Multicellular and aggregative behaviour of Salmonella typhimurium strains is controlled by mutations in the agfD promoter. Mol Microbiol 1998; 28:249-64.
23. Swank RT, Munkres KD. Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulfate. Anal Biochem 1971; 39:462-77.
24. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76:4350-4.
25. Flock JI, Hienz SA, Heimdahl A, Schennings T. Reconsideration of the role of fibronectin binding in endocarditis caused by Staphylococcus aureus. Infect Immun 1996; 64:1876-8.
26. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukaemia cell line (THP-1). Int J Cancer 1980; 26:171-6.
27. Surgalla MJ, Beesley ED. Congo red-agar plating medium for detecting pigmentation in Pasteurella pestis. Appl Microbiol 1969; 18:834-7.
28. Vidal O, Longin R, Prigent-Combaret C, Dorel C, Hooreman M, Lejeune P. Isolation of an Escherichia coli K-12 mutant strain able to form biofilms on inert surfaces: involvement of a new ompR allele that increases curli expression. J Bacteriol 1998; 180:2442-9.
29. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994; 120:771-83.
30. Svanborg C, Hedlund M, Connell H, et al. Bacterial adherence and mucosal cytokine responses: receptors and transmembrane signaling. Ann N Y Acad Sci 1996; 797:177-90.
31. Lee CA. Type III secretion systems: Machines to deliver bacterial proteins into eukaryotic cells? Trends Microbiol 1997; 5:148-56.
32. Connell I, Agace W, Klemm P, Schembri M, Marild S, Svanborg C. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A 1996; 93:9827-32.
33. Ciacci-Woolwine F, Blomfield IC, Richardson SH, Mizel SB. Salmonella flagellin induces tumor necrosis factor alpha in a human promonocytic cell line. Infect Immun 1998; 66:1127-34.
34. Agace W, Hedges S, Andersson U, Andersson J, Ceska M, Svanborg C. Selective cytokine production by epithelial cells following exposure to Escherichia coli. Infect Immun 1993; 61:602-9.
35. Hedlund M, Svensson M, Nilsson A, Duan RD, Svanborg C. Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med 1996; 183:1037-44.
36. Yamamoto Y, Klein TW, Friedman H. Induction of cytokine granulocyte-macrophage colony-stimulating factor and chemokine macrophage inflammatory protein 2 mRNAs in macrophages by Legionella pneumophila or Salmonella typhimurium attachment requires different ligand-receptor systems. Infect Immun 1996; 64:3062-8.
37. Caron E, Gross A, Liautard JP, Dornand J. Brucella species release a specific, protease-sensitive, inhibitor of TNF-alpha expression, active on human macrophage-like cells. J Immunol 1996; 156:2885-93.
38. Boland A, Cornelis GR. Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect Immun 1998; 66:1878-84.
39. Ruckdeschel K, Harb S, Roggenkamp A, et al. Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production. J Exp Med 1998; 187:1069-79.
40. Palmer LE, Hobbie S, Galan JE, Bliska JB. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol Microbiol 1998; 27:953-65.
41. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662-4.
42. Freudenberg MA, Galanos C. Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect Immun 1991; 59:2110-5.
43. Hack CE, De Groot ER, Felt-Bersma RJ, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74:1704-10.
44. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock: association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989; 169:333-8.
45. Schroder JM. The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate. J Exp Med 1989; 170:847-63.
46. Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 1992; 307:97-101.
47. Stone R. Search for sepsis drugs goes on despite past failures. Science 1994; 264:365-7.
48. Carpenter A, Evans TJ, Buurman WA, Bemelmans MH, Moyes D, Cohen J. Differences in the shedding of soluble TNF receptors between endotoxin-sensitive and endotoxin-resistant mice in response to lipopolysaccharide or live bacterial challenge. J Immunol 1995; 155:2005-12.
49. Hopkins W, Gendron-Fitzpatrick A, McCarthy DO, Haine JE, Uehling DT. Lipopolysaccharide-responder and nonresponder C3H mouse strains are equally susceptible to an induced Escherichia coli urinary tract infection. Infect Immun 1996; 64:1369-72.
50. Heumann D, Glauser MP, Calandra T. Molecular basis of host-pathogen interaction in septic shock. Curr Opin Microbiol 1998; 1:49-55.